Merck’s next big thing is (probably) on the way

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

New biotech newsletter launching this Thursday. Don’t miss out.

Hello, everyone. Damian here with a look at a pivotal FDA approval, good news for a small biotech company, and why not all buyouts are worth writing home about.

Read the rest…

Read Original Article: Merck’s next big thing is (probably) on the way »

About The Author